InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by OConnell Daniel Joseph, Chairman & CEO. Officer active across 1 companies, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been logged. The latest transaction was filed on 30 November 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€4,4251,118 shares@ €3.95810.0027% mcap100.0% of flow
Common Stock
SEC:0001209191-21-067613·
€4,4251,118 shares@ €3.95810.0027% mcap50.0% of flow
Common Stock
SEC:0001209191-21-067613:0·
123 shares
Common Stock
SEC:0001209191-21-046029·
123 shares
Common Stock
SEC:0001209191-21-046029:0·
4 of 4 declarations
About OConnell Daniel Joseph
Daniel Joseph O'Connell serves as the President and CEO of Acumen Pharmaceuticals, Inc. He is responsible for the strategic direction and operations of the company. O'Connell plays a key role in developing new initiatives and optimizing the services offered by Acumen.
